Literature DB >> 11275389

Pain site and the effects of amputation pain: further clarification of the meaning of mild, moderate, and severe pain.

Mark P Jensen1, Douglas G Smith, Dawn M Ehde, Lawrence R Robinsin.   

Abstract

Research among persons with cancer pain suggests that the association between pain intensity and pain interference is non-linear. That is, pain begins to have a serious impact on functioning when it reaches a certain threshold level (about 5 on 0--10 scales). Often, a second pain threshold can be identified which, once reached, shows an even greater proportional negative impact on functioning. This finding supports the potential clinical utility of classifying pain as mild, moderate, and severe based on the impact of pain on quality of life, and research among persons with cancer pain supports specific cutoffs (mild: 1--4, moderate: 5--6, severe: 7--10, see Pain 61 (1995) 277) for this classification. The current study sought to replicate the non-linear association between pain and pain interference in a non-cancer pain sample, determine whether the cutoffs that have been identified as optimal for cancer patients are also optimal for persons with pain associated with amputation, and determine whether the optimal cutoffs replicate across pain types (in this case, phantom limb, back, and general pain) within a single sample. Two-hundred and five persons with acquired amputation and phantom limb pain, back pain, or both, rated their average pain intensity and degree of pain interference for each type of pain. The results support a non-linear association between pain intensity and pain interference. However, the optimal cutoffs for classifying mild, moderate and severe pain in the present sample replicated the findings for persons with cancer pain only for back pain -- different optimal cutoffs were found for phantom limb and general pain. Moreover, the degree of pain interference appeared to vary as a function of pain type. The same level of back pain interfered more significantly with daily function than phantom limb pain did after pain levels reached five or more (on a 0--10 scale). These findings have implications for understanding the meaning of pain intensity levels, as well as for the assessment of pain intensity in persons with amputation-related pain.

Entities:  

Mesh:

Year:  2001        PMID: 11275389     DOI: 10.1016/S0304-3959(00)00459-0

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  76 in total

1.  Which pain intensity scale from the Brief Pain Inventory correlates most highly with functional interference scores in patients experiencing taxane-induced arthralgia and myalgia?

Authors:  Nicholas Chiu; Liying Zhang; Daniela Gallo-Hershberg; Rebecca Dent; Leonard Chiu; Mark Pasetka; Jenna van Draanen; Ronald Chow; Henry Lam; Sunil Verma; Jordan Stinson; Erica Stacey; Edward Chow; Carlo DeAngelis
Journal:  Support Care Cancer       Date:  2016-02-11       Impact factor: 3.603

2.  Longitudinal association between pain severity and subsequent opioid use in prescription opioid dependent patients with chronic pain.

Authors:  Margaret L Griffin; Katherine A McDermott; R Kathryn McHugh; Garrett M Fitzmaurice; Robert N Jamison; Roger D Weiss
Journal:  Drug Alcohol Depend       Date:  2016-04-25       Impact factor: 4.492

3.  Clinical benefits, referral practice and cost implications of an in-hospital pain service: results of a service evaluation in a London teaching hospital.

Authors:  Maya Sussman; Elizabeth Goodier; Izabella Fabri; Jessica Borrowman; Sarah Thomas; Charlotte Guest; Carsten Bantel
Journal:  Br J Pain       Date:  2016-10-11

4.  Reasons for opioid use among patients with dependence on prescription opioids: the role of chronic pain.

Authors:  Roger D Weiss; Jennifer Sharpe Potter; Margaret L Griffin; R Kathryn McHugh; Deborah Haller; Petra Jacobs; John Gardin; Dan Fischer; Kristen D Rosen
Journal:  J Subst Abuse Treat       Date:  2014-04-04

5.  Setting standards for severity of common symptoms in oncology using the PROMIS item banks and expert judgment.

Authors:  David Cella; Seung Choi; Sofia Garcia; Karon F Cook; Sarah Rosenbloom; Jin-Shei Lai; Donna Surges Tatum; Richard Gershon
Journal:  Qual Life Res       Date:  2014-06-18       Impact factor: 4.147

6.  The association of sociodemographic and objectively-assessed disease variables with fatigue in systemic sclerosis: an analysis of 785 Canadian Scleroderma Research Group Registry patients.

Authors:  Brooke Levis; Linda Kwakkenbos; Marie Hudson; Murray Baron; Brett D Thombs
Journal:  Clin Rheumatol       Date:  2016-12-10       Impact factor: 2.980

7.  A comparative study of pain in heart failure and non-heart failure veterans.

Authors:  Joy R Goebel; Lynn V Doering; Lorraine S Evangelista; Adeline M Nyamathi; Sally L Maliski; Steven M Asch; Cathy D Sherbourne; Lisa R Shugarman; Andy B Lanto; Angela Cohen; Karl A Lorenz
Journal:  J Card Fail       Date:  2008-11-13       Impact factor: 5.712

8.  Sex and Age Differences in Global Pain Status Among Patients Using Opioids Long Term for Chronic Noncancer Pain.

Authors:  Linda LeResche; Kathleen Saunders; Sascha Dublin; Stephen Thielke; Joseph O Merrill; Susan M Shortreed; Cynthia Campbell; Michael R Von Korff
Journal:  J Womens Health (Larchmt)       Date:  2015-07-08       Impact factor: 2.681

9.  Establishing mild, moderate, and severe scores for cancer-related symptoms: how consistent and clinically meaningful are interference-based severity cut-points?

Authors:  Barbara Given; Charles W Given; Alla Sikorskii; Sangchoon Jeon; Ruth McCorkle; Victoria Champion; David Decker
Journal:  J Pain Symptom Manage       Date:  2007-12-26       Impact factor: 3.612

10.  Use of an innovative model to evaluate mobility in seniors with lower-limb amputations of vascular origin: a pilot study.

Authors:  Claude Vincent; Emilie Demers; Hélène Moffet; Hélène Corriveau; Sylvie Nadeau; Catherine Mercier
Journal:  BMC Geriatr       Date:  2010-09-20       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.